Immunocellular Thera(IMUC)

Description: ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of various cancers. Its products include ICT-107, a dendritic cell (DC) immunotherapy for the treatment of diagnosed glioblastoma multiforme (GBM); ICT-140, a DC-based immunotherapy targets tumor associated antigens on ovarian cancer; and ICT-121, a DC-based immunotherapy targeting CD133 markers and CSCs to treat recurrent GBM and other solid tumor cancers. The company is developing Steam-to-T-Cell immunotherapies for the treatment of cancer. It has license agreements with California Institute of Technology and The Johns Hopkins University. The company was formerly known as Optical Molecular Imaging, Inc. and changed its name to ImmunoCellular Therapeutics, Ltd. in November 2006. ImmunoCellular Therapeutics, Ltd. is based in Westlake Village, California.

---

Keywords: Medicine Biotechnology Cancer Oncology Immunotherapy Treatment Of Cancer Cancer Immunotherapy Immunotherapies Ovarian Cancer Virotherapy Glioblastoma Blastoma Nose Brain Tumor Antigen Stoma Treatment Of Various Cancers Solid Tumor Cancers Steam Glioblastoma Multiforme Molecular Imaging Johns Hopkins University Northwest Biotherapeutics California Institute Of Technology The Johns Hopkins University

---

Home Page: www.eompharma.com

136 Summit Avenue
Montvale, NJ 07645
United States
Phone: 201 351 0605

---

Officers

Exchange: PINK

Country: US

Currency: US Dollar ($)